To the full analysis
Vitrolife stock: growth
VITR.STVitrolife reported $344.93M in revenue for fiscal 2025, down 4.7% on the prior year, up 22.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
17.1%
per year from 2006 to 2025, per share 15.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
19.3%
per year from 2006 to 2025, per share 17.4%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 22.5% | 16.9% | 17.1% |
| Revenue per share | 17.2% | 14.3% | 15.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | 6.5% | 10.4% | 19.3% |
| Free cash flow per share | 1.9% | 8.0% | 17.4% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $17.17M | $1.52M | $1.61M |
| 2007 | $18.95M | $3.62M | $1.51M |
| 2008 | $22.58M | $3.01M | $245.06K |
| 2009 | $27.54M | $3.42M | $1.67M |
| 2010 | $29.84M | $2.93M | $4.85M |
| 2011 | $35.71M | $3.04M | $165.35K |
| 2012 | $36.3M | $33.47M | $4.27M |
| 2013 | $45.4M | $5.64M | $9.79M |
| 2014 | $51.19M | $10.94M | $13.71M |
| 2015 | $72.43M | $18.33M | $17.14M |
| 2016 | $85.84M | $19.09M | $16.8M |
| 2017 | $104.91M | $26.44M | $30.25M |
| 2018 | $115.45M | $31.05M | $16.98M |
| 2019 | $148.42M | $38.38M | $32.71M |
| 2020 | $124.9M | $28.76M | $33.73M |
| 2021 | $168.54M | $34.19M | $32.27M |
| 2022 | $324.28M | $39.51M | $55.05M |
| 2023 | $352.15M | −$386.15M | $63.97M |
| 2024 | $361.88M | $51.44M | $81.72M |
| 2025 | $344.93M | −$502.66M | $46.12M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Nov 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.